Liquidia (LQDA) FCF Margin Growth (3y) (2023 - 2026)
Powered by 
Analysis
Liquidia (LQDA) FCF Margin Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.53 Bn | 625.77 Bn | 17.26 Bn | 1,461.00 |
| 2 | AbbVie | 442.27 Bn | 435.70 Bn | 12.70 Bn | -2,596.00 |
| 3 | Merck | 366.81 Bn | 359.67 Bn | 12.21 Bn | 874.00 |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn | 982.00 |
| 5 | Pfizer | 159.37 Bn | 147.67 Bn | 10.94 Bn | 1,832.00 |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | 1,733.00 |
| 7 | Revolution Medicines | 44.12 Bn | 44.12 Bn | - | - |
| 8 | Incyte | 25.49 Bn | 20.95 Bn | 1.57 Bn | -176.00 |
| 9 | United Therapeutics | 21.55 Bn | 18.89 Bn | 683.80 Mn | 1,592.00 |
| 10 | Liquidia | 6.09 Bn | 5.80 Bn | 160.92 Mn | 16,372.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16,372.00 |
| Mar 31, 2026 | 23,130.00 |
| Dec 31, 2025 | 14,090.00 |
| Sep 30, 2025 | 18,436.00 |
| Jun 30, 2025 | -30,919.00 |
| Mar 31, 2025 | -85,149.00 |
| Dec 31, 2024 | -58,610.00 |
| Sep 30, 2024 | -50,540.00 |
| Jun 30, 2024 | -40,447.00 |
| Mar 31, 2024 | -45,982.00 |
| Dec 31, 2023 | 155,275.00 |